1. Home
  2. MLEC vs MTNB Comparison

MLEC vs MTNB Comparison

Compare MLEC & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moolec Science SA

MLEC

Moolec Science SA

HOLD

Current Price

$6.05

Market Cap

4.7M

Sector

Finance

ML Signal

HOLD

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

HOLD

Current Price

$0.52

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLEC
MTNB
Founded
2008
2013
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
3.9M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
MLEC
MTNB
Price
$6.05
$0.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.2K
14.8K
Earning Date
04-15-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.84
EPS
N/A
N/A
Revenue
N/A
$119,750.00
Revenue This Year
$20.42
N/A
Revenue Next Year
$30.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.21
$0.47
52 Week High
$23.22
$3.09

Technical Indicators

Market Signals
Indicator
MLEC
MTNB
Relative Strength Index (RSI) 35.47 35.26
Support Level $0.60 N/A
Resistance Level $7.95 $0.65
Average True Range (ATR) 0.76 0.06
MACD -0.43 -0.01
Stochastic Oscillator 9.12 13.31

Price Performance

Historical Comparison
MLEC
MTNB

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline, such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's maximum revenues from operations in Argentina.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Share on Social Networks: